StockCanadaNYSE

BHC

Bausch Health Companies Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

6.16USD

-0.2700 (-4.20%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 6.16

P/E—

Dvd Ind Yld—

P/B—

P/S0.2

Curr EV/T12M EBITDA10.9

Mkt Cap (USD)2.3B

Curr EV (USD)22.3B

Per Share Data

EPS T12M-2.96

DPS—

Bk Val Per Sh-4.74

Rev/Sh28.70

Cash/Sh4.88

Curr Shares Out374.0M

FCF/Sh3.78

Cash Flow Analysis

P/CF1.3

Curr P/FCF1.6

CF/NI-1.6

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales16.6%

Eff Interest Rate7.6%

Growth Potential

Dil EPS 1Y Gr423.1%

Cap 1Y Gr-0.4%

BPS 1Y Gr57.5%

R&D To Sales—

Retention Rate100.0%

Rev 1Y Gr6.7%

FCF 1Y Gr-20.4%

Assets 1Y Gr-0.6%

Profitability

EBITDA2.1B

EBIT0.9B

Operating Margin8.1%

Pretax Margin-6.7%

Net Margin-10.1%

ROA-4.2%

ROE86.6%

ROC—

Asset Turnover0.42

Structure

Current Ratio1.44

Quick Ratio0.90

Debt/Assets83.7%

Debt/Com Eq-1171.1%

Net Debt/EBITDA9.20

Tot Debt/Capital109.3%

Gross Margin56.0%

EBIT/Int Exp0.5

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.